Undigested P3 fraction assessed with CP13 and PHF1 antibodies. A schematic of antibody epitopes is presented. Blot represents P3 fraction from 3 animals of classes I, II and IV. Class I mice at ages 587, 662, and 646 days left to right, class II animals at ages 735, 592, and 658 days left to right, and class IV mice at ages 530, 466, and 639 days left to right. For both blots, 5 μg of total protein was loaded on the gel. Antibody: CP13 (1/500) and PHF1 (1/500). (TIFF 199 kb
Figure S1. Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hipp...
Figure S5. Localization of phosphotau immunoreactivity versus G85R-SOD1:YFP pathology in bigenic JNP...
Additional file 1: Fig. S1. Generation and genomic identification of hTau368 mice. Fig. S2. hTau368 ...
Class I mice. These figures represent the counterparts of Fig. 4. stained with MC1, CP27, RZ3 and PH...
Class III mice. These figures represent the counterparts of Fig. 6. stained with MC1, CP27, RZ3 and ...
Class II mice. These figures represent the counterparts of Fig. 5. stained with MC1, CP27, RZ3 and P...
Pathology in aged Tg mice assessed for insoluble Tau species. These data represent the counterparts ...
Appearance of disease-associated symptoms in TgTauP301L mice three genetic backgrounds. Time points ...
Figure S1. Western blot results of tau expression in mice expressing pro- or anti-aggregant human ta...
Single Nucleotide Polymorphism (SNP) profiling of congenic and incipient congenic lines. (DOCX 11Â k...
T5x mice exhibit increased levels of Tau phosphorylation and misfolding. (A) The ratio of phosphoryl...
Figure S1. CSF was collected from patients and controls by a lumbar puncture, obtaining about 10 ml ...
Figure S1. Accumulation of soluble, hyperphosphorylated tau in A152T-expressing mice. Figure S2. Inc...
Figure S1. TIA1 antibodies demonstrate significant variability. Four commercial TIA1 antibodies were...
Supplementary data Table S1. Animal numbers (genotype and sex). Table S2. ODT ANOVA factors. Normali...
Figure S1. Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hipp...
Figure S5. Localization of phosphotau immunoreactivity versus G85R-SOD1:YFP pathology in bigenic JNP...
Additional file 1: Fig. S1. Generation and genomic identification of hTau368 mice. Fig. S2. hTau368 ...
Class I mice. These figures represent the counterparts of Fig. 4. stained with MC1, CP27, RZ3 and PH...
Class III mice. These figures represent the counterparts of Fig. 6. stained with MC1, CP27, RZ3 and ...
Class II mice. These figures represent the counterparts of Fig. 5. stained with MC1, CP27, RZ3 and P...
Pathology in aged Tg mice assessed for insoluble Tau species. These data represent the counterparts ...
Appearance of disease-associated symptoms in TgTauP301L mice three genetic backgrounds. Time points ...
Figure S1. Western blot results of tau expression in mice expressing pro- or anti-aggregant human ta...
Single Nucleotide Polymorphism (SNP) profiling of congenic and incipient congenic lines. (DOCX 11Â k...
T5x mice exhibit increased levels of Tau phosphorylation and misfolding. (A) The ratio of phosphoryl...
Figure S1. CSF was collected from patients and controls by a lumbar puncture, obtaining about 10 ml ...
Figure S1. Accumulation of soluble, hyperphosphorylated tau in A152T-expressing mice. Figure S2. Inc...
Figure S1. TIA1 antibodies demonstrate significant variability. Four commercial TIA1 antibodies were...
Supplementary data Table S1. Animal numbers (genotype and sex). Table S2. ODT ANOVA factors. Normali...
Figure S1. Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hipp...
Figure S5. Localization of phosphotau immunoreactivity versus G85R-SOD1:YFP pathology in bigenic JNP...
Additional file 1: Fig. S1. Generation and genomic identification of hTau368 mice. Fig. S2. hTau368 ...